A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19

BACKGROUND: Use of renin-angiotensin-aldosterone system inhibitors in coronavirus disease 2019 (COVID-19) patients lacks evidence and is still controversial. This study was designed to investigate effects of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhongchao, Zhang, Dewei, Wang, Shengming, Jin, Yanhua, Huan, Jianbo, Wu, Yue, Xia, Cheng, Li, Zhe, Qi, Xingshun, Zhang, Duanzhen, Han, Xiumin, Zhu, Xianyang, Qu, Ying, Wang, Qiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523417/
https://www.ncbi.nlm.nih.gov/pubmed/32969367
http://dx.doi.org/10.12659/MSM.926651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523417/
https://www.ncbi.nlm.nih.gov/pubmed/32969367
http://dx.doi.org/10.12659/MSM.926651

Ejemplares similares